Google
Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Cerebrovascular Accident in Sickle Cell Anemia
source: Family Practice Notebook
year: 2018
summary/abstract:Cerebrovascular Accident in Sickle Cell Anemia:
II. Epidemiology: Prevalence
Children: 5%
Highest risk at ages 2 to 5 years old with Sickle Cell Anemia
A. Silent cerebral infarct occurs in up to 25% of children by age 6 years old
B. Young adult (age <20): 11%
C. Age 45 years old: 24%
D. Lifetime risk: 25%
III. Pathophysiology
A. Silent Cerebral Infarction
1. Silent CVA may occur in up to 25% of children with Sickle Cell Anemia by age 6 years old
2. May present as cognitive deficits or learning difficulties
3. May be prevented with regular Blood Transfusions (see below)
B. Ischemic Stroke
1. Most common in children and teens
2. Internal Carotid Artery thrombosis
C. Hemorrhagic Stroke
1. Most common in ages 20 to 30 years old
+myBinderRelated Content
-
Effect of crizanlizumab on pain crises in subgroups of patients with sickle cell disease: A SUSTAIN study analysisThe cell adhesion molecule P-selectin pl...
-
Chronic opioid therapy is more strongly associated with central sensitization in sickle cell disease than clinical p...Central nervous system sensitization (CS...
-
Sickle Cell & PregnancySickle cell disease often becomes more s...
-
Sickle Cell Disease Research Shows Progress in Preventing Related Complications and DeathStudies aim to limit pain crises, preven...
-
Small chips, big impact: MSU researcher studies cardiovascular, sickle cell diseaseA Mississippi State University researche...
-
Cognitive Function may be Affected in Adults With Sickle Cell Disease, Study SuggestsAdults with sickle cell disease score wo...
-
Researchers ID key drivers of heart complications in sickle cell anemiaStudy opens path to earlier diagnosis, t...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.